Distinct modes of action applied by transcription factors STAT1 and IRF1 to initiate transcription of the IFN-γ-inducible gbp2 gene

被引:97
作者
Ramsauer, Katrin
Farlik, Matthias
Zupkovitz, Gordin
Seiser, Christian
Kroeger, Andrea
Hauser, Hansjorg
Decker, Thomas [1 ]
机构
[1] Univ Vienna, Dept Microbiol & Immunol, Max F Perutz Labs, A-1030 Vienna, Austria
[2] Univ Vienna, Dept Biochem Med, Max F Perutz Labs, A-1030 Vienna, Austria
[3] Gesellschaft Biotechol Forsch, D-38124 Braunschweig, Germany
基金
奥地利科学基金会;
关键词
chromatin; interferon; signal transduction; interferon regulatory factor;
D O I
10.1073/pnas.0610944104
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
A subgroup of genes induced by IFN-gamma requires both STAT1 and IRF1 for transcriptional activation. Using WT, stat1(-/-), or irf1(-/-) cells, we analyzed the changes induced by IFN-gamma in gbp2 promoter chromatin. STAT1 associated with the promoter independently of IRF1 and played an essential role in the ordered recruitment of the coactivator/histone acetyl transferase CREB-binding protein (CBP) and the histone deacetylase HDAC1. Hyperacetylation of histone 4 also required STAT1. Phosphorylation at S727 in the transactivating domain increased transcriptional activity of STAT1. In cells expressing a STAT1S727A-mutant CBP recruitment, histone 4 hyperacetylation and RNA polymerase 11 association with the gbp2 promoter were strongly reduced. IRF1 association with the gbp2 promoter followed that of STAT1, but STAT1 association with DNA or histone hyperacetylation were not necessary for IRF1 binding. RNA polymerase 11 association with the gbp2 promoter required both STAT1 and IRF1, suggesting that both proteins mediate essential steps in transcriptional activation. IRF1, but not STAT1, was found to coimmunoprecipitate with RNA polymerase II. Together, the data support the assumption that the main role of STAT1 in activating gbp2 transcription is to provide transcriptionally competent chromatin, whereas the function of IRF1 may lie in directly contacting RNA polymerase II-containing transcriptional complexes.
引用
收藏
页码:2849 / 2854
页数:6
相关论文
共 48 条
[1]   Genomic organization and chromosomal localization of a new member of the murine interferon-induced guanylate-binding protein family [J].
Anderson, SL ;
Carton, JM ;
Zhang, X ;
Rubin, BY .
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 1999, 19 (05) :487-494
[2]  
BACCARINI M, 1985, J IMMUNOL, V134, P2658
[3]   COMBINATORIAL ASSOCIATION AND ABUNDANCE OF COMPONENTS OF INTERFERON-STIMULATED GENE FACTOR-3 DICTATE THE SELECTIVITY OF INTERFERON RESPONSES [J].
BLUYSSEN, HAR ;
MUZAFFAR, R ;
VLIESTSTRA, RJ ;
VANDERMADE, ACJ ;
LEUNG, S ;
STARK, GR ;
KERR, IM ;
TRAPMAN, J ;
LEVY, DE .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (12) :5645-5649
[4]  
BRIKEN V, 1995, MOL CELL BIOL, V15, P975
[5]   Induction of interferon-stimulated gene expression and antiviral responses require protein deacetylase activity [J].
Chang, HM ;
Paulson, M ;
Holko, M ;
Rice, CM ;
Williams, BRG ;
Marié, I ;
Levy, DE .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (26) :9578-9583
[6]   Transcription factor activity of STAT proteins: structural requirements and regulation by phosphorylation and interacting proteins [J].
Decker, T ;
Kovarik, P .
CELLULAR AND MOLECULAR LIFE SCIENCES, 1999, 55 (12) :1535-1546
[7]   Serine phosphorylation of STATs [J].
Decker, T ;
Kovarik, P .
ONCOGENE, 2000, 19 (21) :2628-2637
[8]   Targeted disruption of the mouse STAT1 results in compromised innate immunity to viral disease [J].
Durbin, JE ;
Hackenmiller, R ;
Simon, MC ;
Levy, DE .
CELL, 1996, 84 (03) :443-450
[9]   Global changes in STAT target selection and transcription regulation upon interferon treatments [J].
Hartman, SE ;
Bertone, P ;
Nath, AK ;
Royce, TE ;
Gerstein, M ;
Weissman, S ;
Snyder, M .
GENES & DEVELOPMENT, 2005, 19 (24) :2953-2968
[10]   Regulation of the type IIFN induction: a current view [J].
Honda, K ;
Yanai, H ;
Takaoka, A ;
Taniguchi, T .
INTERNATIONAL IMMUNOLOGY, 2005, 17 (11) :1367-1378